Glucagon-like peptide-1 receptor agonists and tirzepatide are associated with reduced mortality, cardiovascular, and psychiatric risks in patients with hidradenitis suppurativa and type 2 diabetes and/or obesity: a retrospective cohort study.

Mounjaro (tirzepatide) - Eli Lilly

Zepbound (tirzepatide) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42741157

Aida Zani; Diamant Thaçi; Henning Olbrich; Inga C Brouer; Ralf J Ludwig

Sep 16, 2026